Restricted Access:
Framework Investing Valuation Workshop #1 for Gilead Sciences (GILD)
This small-group meeting discussed structural and behavioral factors in the Gilead analysis and started in on analyzing the company’s valuation drivers. We made it through an analysis of the revenue streams for Gilead’s hepatitis c and HIV treatment franchises and will pick up the rest of the analysis next week.